1. Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma 
Gregory M. Cote, Ephraim P. Hochberg, Alona Muzikansky, Fred H. Hochberg, Jan Drappatz, Steven L. McAfee, Tracy T. Batchelor, Ann S. LaCasce, David C. Fisher, Jeremy S. Abramson, Philippe Armand, Yi-Bin Chen 
Biology of Blood and Marrow Transplantation 
Volume 18, Issue 1, Pages (January 2012)
DOI: /j.bbmt
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Overall (OS) and progression-free survival (PFS). (B) OS and PFS by pretransplantation status. (A) The OS and PFS are shown by primary or secondary CNS lymphoma from the day of transplantation. Median time points have not yet been reached. (B) The OS and PFS are shown by pretransplantation complete response (CR) or partial response (PR) from the day of transplantation. Two patients are not shown: 1 with either progressive disease at transplantation (currently alive without disease recurrence) and 1 with stable disease at transplantation (relapsed within 3 months, currently still alive in CR after salvage therapy).
Biology of Blood and Marrow Transplantation  , 76-83DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions